PTCL-nos

Clinical trials for PTCL-nos explained in plain language.

Never miss a new study

Get alerted when new PTCL-nos trials appear

Sign up with your email to follow new studies for PTCL-nos, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New drug combo targets Hard-to-Treat lymphomas

Disease control Recruiting now

This study tests a new drug called AZD3470, alone or with pembrolizumab (Keytruda), in people with certain blood cancers like lymphoma. The goal is to check safety, side effects, and whether the drug shrinks tumors. About 161 adults and teens will take part.

Matched conditions: PTCL-NOS

Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

PTCL-nos

Get alerted when new PTCL-nos trials appear

New drug combo targets Hard-to-Treat lymphomas